p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
p16, COX-2, and Ki67 may not be prognostic for ipsilateral IBC in women with DCIS.
Authors
- Olivier Loudig (ORCID: https://orcid.org/0000-0001-5677-4716)
- Larissa L. White (ORCID: https://orcid.org/0000-0001-9364-2704)
- Robert T. Greenlee (ORCID: https://orcid.org/0000-0002-0618-7895)
- Fergus J. Couch (ORCID: https://orcid.org/0000-0001-9417-9985)
- Mindy S. Ginsberg (ORCID: https://orcid.org/0000-0002-4916-1273)
- Dhananjay Chitale (ORCID: https://orcid.org/0000-0002-4421-6431)
- Chenxin Zhang (ORCID: https://orcid.org/0009-0006-3569-0250)
- Stacey Honda (ORCID: https://orcid.org/0000-0001-5496-3759)
- Thomas E. Rohan (ORCID: https://orcid.org/0000-0001-6897-4045)
- Azadeh Stark (ORCID: https://orcid.org/0000-0002-4252-8263)
- Xiaonan Xue (ORCID: https://orcid.org/0000-0003-2872-8119)
- Yihong Wang
Institutions
- Albert Einstein College of Medicine (US)
- Marshfield Clinic (US)
- Hackensack University Medical Center (US)
- Mayo Clinic (US)
- Kaiser Permanente (US)
- Henry Ford Health System (US)
- Providence College (US)
- Brown University (US)
- Rhode Island Hospital (US)
- Marshfield Clinic (US)
- Kaiser Permanente Center for Health Research (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Center for Discovery (US)
- Hawaii Permanente Medical Group (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-0143
- Citations
- 1
- Primary Topic
- Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Breast Cancer Research Foundation
- National Institutes of Health
- National Cancer Institute